These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

450 related articles for article (PubMed ID: 26571100)

  • 21. Development of a genome editing technique using the CRISPR/Cas9 system in the industrial filamentous fungus Aspergillus oryzae.
    Katayama T; Tanaka Y; Okabe T; Nakamura H; Fujii W; Kitamoto K; Maruyama J
    Biotechnol Lett; 2016 Apr; 38(4):637-42. PubMed ID: 26687199
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Therapeutic applications of CRISPR RNA-guided genome editing.
    Koo T; Kim JS
    Brief Funct Genomics; 2017 Jan; 16(1):38-45. PubMed ID: 27562951
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CRISPR/Cas9-Based Genome Editing for Disease Modeling and Therapy: Challenges and Opportunities for Nonviral Delivery.
    Wang HX; Li M; Lee CM; Chakraborty S; Kim HW; Bao G; Leong KW
    Chem Rev; 2017 Aug; 117(15):9874-9906. PubMed ID: 28640612
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Exploring the potential of genome editing CRISPR-Cas9 technology.
    Singh V; Braddick D; Dhar PK
    Gene; 2017 Jan; 599():1-18. PubMed ID: 27836667
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Silencing of end-joining repair for efficient site-specific gene insertion after TALEN/CRISPR mutagenesis in Aedes aegypti.
    Basu S; Aryan A; Overcash JM; Samuel GH; Anderson MA; Dahlem TJ; Myles KM; Adelman ZN
    Proc Natl Acad Sci U S A; 2015 Mar; 112(13):4038-43. PubMed ID: 25775608
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Diving into marine genomics with CRISPR/Cas9 systems.
    Momose T; Concordet JP
    Mar Genomics; 2016 Dec; 30():55-65. PubMed ID: 27742404
    [TBL] [Abstract][Full Text] [Related]  

  • 27. CRISPR/Cas9: an advanced tool for editing plant genomes.
    Samanta MK; Dey A; Gayen S
    Transgenic Res; 2016 Oct; 25(5):561-73. PubMed ID: 27012546
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Targeted genome editing in the rare actinomycete Actinoplanes sp. SE50/110 by using the CRISPR/Cas9 System.
    Wolf T; Gren T; Thieme E; Wibberg D; Zemke T; Pühler A; Kalinowski J
    J Biotechnol; 2016 Aug; 231():122-128. PubMed ID: 27262504
    [TBL] [Abstract][Full Text] [Related]  

  • 29. RNA-guided genome editing in plants using a CRISPR-Cas system.
    Xie K; Yang Y
    Mol Plant; 2013 Nov; 6(6):1975-83. PubMed ID: 23956122
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Genome Editing in Clostridium saccharoperbutylacetonicum N1-4 with the CRISPR-Cas9 System.
    Wang S; Dong S; Wang P; Tao Y; Wang Y
    Appl Environ Microbiol; 2017 May; 83(10):. PubMed ID: 28258147
    [No Abstract]   [Full Text] [Related]  

  • 31. Harnessing heterologous and endogenous CRISPR-Cas machineries for efficient markerless genome editing in Clostridium.
    Pyne ME; Bruder MR; Moo-Young M; Chung DA; Chou CP
    Sci Rep; 2016 May; 6():25666. PubMed ID: 27157668
    [TBL] [Abstract][Full Text] [Related]  

  • 32. CRISPR/Cas9: An RNA-guided highly precise synthetic tool for plant genome editing.
    Demirci Y; Zhang B; Unver T
    J Cell Physiol; 2018 Mar; 233(3):1844-1859. PubMed ID: 28430356
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In-Yeast Engineering of a Bacterial Genome Using CRISPR/Cas9.
    Tsarmpopoulos I; Gourgues G; Blanchard A; Vashee S; Jores J; Lartigue C; Sirand-Pugnet P
    ACS Synth Biol; 2016 Jan; 5(1):104-9. PubMed ID: 26592087
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Simplified CRISPR-Cas genome editing for Saccharomyces cerevisiae.
    Generoso WC; Gottardi M; Oreb M; Boles E
    J Microbiol Methods; 2016 Aug; 127():203-205. PubMed ID: 27327211
    [TBL] [Abstract][Full Text] [Related]  

  • 35. CRISPR/Cas9 Platforms for Genome Editing in Plants: Developments and Applications.
    Ma X; Zhu Q; Chen Y; Liu YG
    Mol Plant; 2016 Jul; 9(7):961-74. PubMed ID: 27108381
    [TBL] [Abstract][Full Text] [Related]  

  • 36. CRISPR-Cas9 therapeutics in cancer: promising strategies and present challenges.
    Yi L; Li J
    Biochim Biophys Acta; 2016 Dec; 1866(2):197-207. PubMed ID: 27641687
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Analysis of CRISPR gene drive design in budding yeast.
    Yan Y; Finnigan GC
    Access Microbiol; 2019; 1(9):e000059. PubMed ID: 32974560
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Guerrilla eugenics: gene drives in heritable human genome editing.
    Cutter AD
    J Med Ethics; 2023 Jul; ():. PubMed ID: 37407027
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Gene Drives and Genome Modification in Nonhuman Animals: A Concern for Informed Consent?
    Smolenski J
    Camb Q Healthc Ethics; 2019 Jan; 28(1):93-99. PubMed ID: 30570468
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Challenges in Developing Efficient and Robust Synthetic Homing Endonuclease Gene Drives.
    Verkuijl SAN; Ang JXD; Alphey L; Bonsall MB; Anderson MAE
    Front Bioeng Biotechnol; 2022; 10():856981. PubMed ID: 35419354
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.